2023 IEEE-EMBS International Conference on Body Sensor Networks

BioSensics is thrilled to sponsor, exhibit, and present at the IEEE-EMBS International Conference on Body Sensor Networks at the MIT Media Lab, Cambridge, MA next week. At the event, we will be giving 5 poster presentations that will highlight our efforts in creating digital measurement tools and sensor-based biomarkers for various conditions, such as ALS, dementia, and Alzheimer's. 

On Monday, October 9, our team will be presenting a poster titled "Toward Remote Assessment of Cognitive Impairment using Digital Speech Features". The work is supported by the NIH and is in collaboration with Baylor College of Medicine. 

On Tuesday, October 10, our team will present a poster titled "Continuous Monitoring of Upper Limb Function During Activities of Daily Living using a Wearable Sensor". 

The work is supported by the NIH and is in collaboration with Spaulding Rehabilitation Hospital. 

On Wednesday, October 11, our team will be presenting three posters:

• "Remote Monitoring of Instrumental Activities of Daily Living to Differentiate Between Individuals with Moderate to Severe Impairment, Mild Cognitive Impairment, and Cognitively Health." Collaborator: Baylor College of Medicine.

• "Multi-modal remote monitoring of ALS using wearable sensors and digital assessments". Collaborator: Penn State Health. 

• "Tele-Frailty Meter: Bridging Distances in Cognitive Frailty Assessment with a 20-Second Video-Based Approach". Collaborator: Baylor College of Medicine. 

Additionally, on Wednesday, October 11, I will be participating in the panel discussion "Fostering Synergy for the Future of Digital Health – Insights from Industry Innovators".

If you are interested in meeting our team during the meeting, obtaining copies of our posters, or exploring potential collaboration and partnership opportunities, please contact us.

About BioSensics: BioSensics is the leader in developing wearable sensors and digital health technologies for clinical trials and research, remote patient monitoring, and health assessments. Founded in 2007 by three scientists from Harvard, BioSensics has created new paradigms in using wearable sensors in healthcare and revolutionized the medical alert industry by creating technologies that are now used by thousands of older adults.

BioSensics is the only company that offers comprehensive end-to-end solutions and services for the acquisition of digital measures and biomarkers in clinical trials and research. BioSensics designs and validates all elements of their solutions, including wearable sensors, software, and algorithms. Our experienced research team extends complete scientific and technical consultation services, such as study design and protocol development, in addition to statistical analysis. Furthermore, BioSensics clinical operations team provides comprehensive operational and logistics support for clinical trial projects. 

BioSensics has received over $50M in research and development program support from the U.S. National Institute of Health (NIH). In 2022, BioSensics was chosen by NIH to create remote measurement technologies for use in clinical trials involving people with rare diseases.